Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0000950170-25-113822

Principal Accounting Officer sold 461 shares at $12.09 ($5,573)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Breedlove Robert Charles Principal Accounting Officer 2025-09-05 Sale −461 $12.09 $5,573 47,931 D
Open-market sales · 461 sh · avg $12.09 · $5,573
Loading xslF345X05/ownership.xml…